Carbogen and Nicotinamide With Radiation Feasible for Bladder Cancer

THURSDAY, July 8, 2021 -- The use of concurrent carbogen and nicotinamide (CON) with radiation therapy is feasible for patients with muscle invasive bladder cancer (MIBC) in the Australian setting, according to a study published online June 30 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news